Upcoming Blue Chip Pre-Earnings Overview

The Dow Jones Industrial Average (DJI) and S&P 500 both climbed more than 1% after a tough January. So far, the indexes are still in the red.

We’re still in the thick of earnings season, so let’s take a look at some of the most anticipated releases to be released this week!

PFIZER – 8/02

Pfizer will be looking to display strength as it approaches its quarterly earnings report on February 8th, 2022. In that report, analysts expect Pfizer to post earnings of $0.84 per share, which would mark year-over-year growth of 100% on Pfizer’s share price. The most recent estimates put their quarterly revenue at $23.89 billion, an increase of 104.43% from the same period last year.

It’s also worth noting that analyst estimates for Pfizer have recently changed. Typically, these changes reflect the most recent short-term business trends, which might shift quickly. As a result, positive estimate revisions can be interpreted as a good sign for the company’s overall performance.

TOYOTA – 8/02*

Since its inception, Toyota Motor Corporation has seen a rising trend and will be looking to show strength when it reports its upcoming quarterly earnings. This quarter’s EPS is forecast to be $3.74, a decline of 34% from the same period last year. Currently, revenue forecasts predict $67.26 billion in sales, a reduction of 13.82% from the preceding year’s third-quarter total of $70.2 billion.

Analysts anticipate earnings of $18.31 per share and revenue of $280.62 billion for the entire year. These totals would be up +22.15 and 9.1% from last year, respectively.

*estimated earnings release date

WALT DISNEY – 9/02*

It’s earnings season, and that means Disney gets to show the world how its holiday quarter played out. The streaming giant plummeted to a 15-month low in January, extending a significant downturn that saw Walt Disney stock lose more than 36% of its value.

Disney subscription growth has slowed dramatically, while churn has increased, as many viewers have been dissatisfied with substandard programming, particularly in the Star Wars and Marvel ecosystems. Cruise ships and theme parks are also underperforming, and movie releases have fallen short of analyst expectations.

*estimated earnings release date

COCA-COLA – 10/02

The world’s largest soft drink manufacturer is expected to report its fourth-quarter earnings of $0.41 per share, representing a year-over-year decline of over 12% from $0.47 per share seen in the same quarter last year. But revenue would rise by nearly 4% to $8.94 billion.

According to Coke’s most recent quarterly report, the company is already well on its way to recovery. Organic sales climbed by 14% in the third quarter, beating expectations and putting the company well ahead of PepsiCo. A greater focus on on-the-go beverages could help it maintain its lead over the competition as the pandemic winds down.

*estimated earnings release date

PEPSI – 10/02

The Harrison, New York-based global food and beverage giant is forecast to report fourth-quarter earnings of $1.52 per share, a year-over-year increase of more than 3% from $1.47 per share in the same period last year.

The worldwide food, snack, and beverage corporation would increase revenue by nearly 9% to $24.35 billion. It’s worth mentioning that Pepsi stock has consistently outperformed consensus earnings estimates over the last two years.

PepsiCo has had to raise pricing and cut production due to supply-chain issues. When the beverage firm reveals its financial results for the fourth quarter of 2021, investors will want to know if it is winning this battle.

ASTRAZENECA – 10/02

AstraZeneca slipped 2.81% to $55.72 Friday, as the stock market saw a volatile trading session. This was the ADR’s second consecutive day of losses. AstraZeneca’s stock price has also fallen by $8.49 from its 52-week high ($64.21) reached on November 2nd of last year. Over the previous 60 days, the Zacks Consensus Estimate for its current-year earnings has been revised 1.5 percent down.

AstraZeneca’s share price has gained 13.3% over the past year, compared to the industry’s 15.7% rise. Revenues from AstraZeneca’s COVID-19 vaccination increased by 32% in the first nine months of 2021 to $25.4 billion. However, even excluding it, the growth rate was still impressive at 21%.

MODERNA – 24/02

Moderna stock has lost about a third of its value in 2022 and is currently trading at around $160 per share. With the recent sell-off, the stock price is now approximately 55% lower than in November 2021. It has also been a difficult time for stocks like Novavax and BioNTech.

Moderna is expected to earn $27.85 billion in 2022, making the stock relatively cheap in the current market environment. At this time, it appears as though the stock needs multiple expansions to see long-term gains from its current levels. It’s also unclear whether the market is ready to pay a premium at a time when the company’s 2023 revenue remains unknown.

CFD Trading Explained

A contract for difference (CFD) is an agreement between a buyer and a seller to exchange stock prices at a set time. A trader would not own the stock or the asset when trading in a Contract for Difference. Stock CFDs are traded in specified amounts depending on the value of 100 shares of a specific company. One of the benefits of trading stock CFDs is when using leverage you are able to open bigger trades with less amount deposited. Leverage can magnify gains and losses, so it’s important for traders to approach with caution.

Trading with tixee

tixee’s goal is to connect traders to global markets by offering a suite of tools and account options that far exceed expectations. Whether you use a computer, tablet, or a smartphone to trade, both are supported with tixee’s various trading platforms, as well as the browser-based Web Trader and Simple Trader. tixee offers Blue Chip CFDs, like the ones above and more for traders to get in on the international markets easily.

Sources

https://www.zacks.com/stock/news/1851170/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know

https://markets.businessinsider.com/news/stocks/toyota-motor-corporation-tm-stock-moves–0-07percent–what-you-should-know-10999470

https://www.fxempire.com/forecasts/article/wall-street-week-ahead-earnings-kkr-walt-disney-coca-cola-twitter-and-pepsico-in-focus-889448